Scientists identify gene contributing to prostate cancer drug resistance
Researchers have discovered how a gene involved in regulating hormone receptors may contribute to drug…
Browsing: Prostate Cancer
Mayo Clinic discovers biological markers that could guide treatment for prostate cancer
Genetic alterations in low-risk prostate cancer diagnosed by needle biopsy can identify men that harbour…
Inflammatory bowel disease linked to prostate cancer
Men with inflammatory bowel disease have four to five times higher risk of being diagnosed…
One test to diagnose them all: researchers exploit cancers’ unique DNA signature
Abu Sina, The University of Queensland; Laura G. Carrascosa, The University of Queensland, and Matt…
Study identifies a genetic driver of deadly prostate cancer
A new study has identified a novel molecular driver of lethal prostate cancer, along with…
Surgery & combination therapy optimises results in aggressive prostate cancer management
Men presenting with aggressive prostate cancer – Gleason Score of 9 or 10 – comprise…
First blood based biomarker in response to the treatment of the most aggressive prostate cancer
The most aggressive type of prostate cancer, castration-resistant prostate cancer, can be treated with two…
Prostate cancer radiotherapy more precisely targeted with nuclear medicine imaging
Current standard imaging techniques for initial staging of prostate cancer often underestimate the extent of…
Anti-hormone therapy linked with higher heart failure risk in prostate cancer patients
Androgen deprivation therapy was associated with a 72 percent higher risk of heart failure in…
Cancer trial shows treating the prostate with radiotherapy improves survival
Treating the prostate with radiotherapy alongside standard treatment led to an 11 per cent increase…